These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30870006)

  • 1. Long noncoding RNA CDKN2B-AS1 interacts with transcription factor BCL11A to regulate progression of cerebral infarction through mediating MAP4K1 transcription.
    Lei JJ; Li HQ; Mo ZH; Liu KJ; Zhu LJ; Li CY; Chen WL; Zhang L
    FASEB J; 2019 Jun; 33(6):7037-7048. PubMed ID: 30870006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DLX6-AS1 promotes cell proliferation, migration and EMT of gastric cancer through FUS-regulated MAP4K1.
    Wu Q; Ma J; Meng W; Hui P
    Cancer Biol Ther; 2020; 21(1):17-25. PubMed ID: 31591939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA CDKN2B-AS1 contributes to atherosclerotic plaque formation by forming RNA-DNA triplex in the CDKN2B promoter.
    Ou M; Li X; Zhao S; Cui S; Tu J
    EBioMedicine; 2020 May; 55():102694. PubMed ID: 32335370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA CDKN2B-AS1 reduces inflammatory response and promotes cholesterol efflux in atherosclerosis by inhibiting ADAM10 expression.
    Li H; Han S; Sun Q; Yao Y; Li S; Yuan C; Zhang B; Jing B; Wu J; Song Y; Wang H
    Aging (Albany NY); 2019 Mar; 11(6):1695-1715. PubMed ID: 30926762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription.
    Xie X; Lin J; Fan X; Zhong Y; Chen Y; Liu K; Ren Y; Chen X; Lai D; Li X; Li Z; Tang A
    Cell Death Dis; 2021 Feb; 12(2):201. PubMed ID: 33608495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA CDKN2B-AS1 silencing protects against esophageal cancer cell invasion and migration by inactivating the TFAP2A/FSCN1 axis.
    Zhu JL; Xue WB; Jiang ZB; Feng W; Liu YC; Nie XY; Jin LY
    Kaohsiung J Med Sci; 2022 Dec; 38(12):1144-1154. PubMed ID: 36161699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing lncRNA CDKN2B-AS1 Alleviates Childhood Asthma Progression Through Inhibiting ZFP36 Promoter Methylation and Promoting NR4A1 Expression.
    Chen Z; Fan N; Shen G; Yang J
    Inflammation; 2023 Apr; 46(2):700-717. PubMed ID: 36422840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDKN2B antisense RNA 1 suppresses tumor growth in human colorectal cancer by targeting MAPK inactivator dual-specificity phosphatase 1.
    Pan J; Lin M; Xu Z; Xu M; Zhang J; Weng Z; Lin B; Lin X
    Carcinogenesis; 2021 Nov; 42(11):1399-1409. PubMed ID: 34436551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of long non-coding RNA CDKN2B-AS1 suppresses the progression of breast cancer by miR-122-5p/STK39 axis.
    Qin S; Ning M; Liu Q; Ding X; Wang Y; Liu Q
    Bioengineered; 2021 Dec; 12(1):5125-5137. PubMed ID: 34374638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA TNRC6C-AS1 promotes methylation of STK4 to inhibit thyroid carcinoma cell apoptosis and autophagy via Hippo signalling pathway.
    Peng X; Ji C; Tan L; Lin S; Zhu Y; Long M; Luo D; Li H
    J Cell Mol Med; 2020 Jan; 24(1):304-316. PubMed ID: 31657132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK/ERK pathway.
    Sun J; Guo Y; Bie B; Zhu M; Tian H; Tian J; Li J; Yang Y; Ji F; Kong G; Li Z
    J Cell Biochem; 2020 Jan; 121(1):443-457. PubMed ID: 31231887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/SMAD3 axis and predicts a poor prognosis.
    Xu C; Zhai J; Fu Y
    Neoplasma; 2020 Jul; 67(4):782-793. PubMed ID: 32305052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linear isoforms of the long noncoding RNA CDKN2B-AS1 regulate the c-myc-enhancer binding factor RBMS1.
    Hubberten M; Bochenek G; Chen H; Häsler R; Wiehe R; Rosenstiel P; Jepsen S; Dommisch H; Schaefer AS
    Eur J Hum Genet; 2019 Jan; 27(1):80-89. PubMed ID: 30108282
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Luo Y; Tao H; Jin L; Xiang W; Guo W
    Cancer Biother Radiopharm; 2020 Feb; 35(1):58-65. PubMed ID: 31724892
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene expression and rs2383207 variant with breast cancer risk and survival.
    Kattan SW; Hobani YH; Shaheen S; Mokhtar SH; Hussein MH; Toraih EA; Fawzy MS; Abdalla HA
    Cell Mol Biol Lett; 2021 Apr; 26(1):14. PubMed ID: 33849428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA DSCAM-AS1 functions as an oncogene in non-small cell lung cancer by targeting BCL11A.
    Liao J; Xie N
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1087-1092. PubMed ID: 30779076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New findings in the roles of Cyclin-dependent Kinase inhibitors 2B Antisense RNA 1 (
    Yuan W; Zhang W; Zhang W; Ruan ZB; Zhu L; Liu Y; Mi YY; Zhang LF
    Bioengineered; 2020 Dec; 11(1):1084-1098. PubMed ID: 33054494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA CDKN2B-AS1 promotes osteosarcoma by increasing the expression of MAP3K3 via sponging miR-4458.
    Gui D; Cao H
    In Vitro Cell Dev Biol Anim; 2020 Jan; 56(1):24-33. PubMed ID: 31950433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpressed lncRNA CDKN2B-AS1 is an independent prognostic factor for liver cancer and promotes its proliferation.
    Zhuang H; Cao G; Kou C; Li D
    J BUON; 2019; 24(4):1441-1448. PubMed ID: 31646789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linear and circular CDKN2B-AS1 expression is associated with Inflammatory Bowel Disease and participates in intestinal barrier formation.
    Rankin CR; Lokhandwala ZA; Huang R; Pekow J; Pothoulakis C; Padua D
    Life Sci; 2019 Aug; 231():116571. PubMed ID: 31207308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.